Article thumbnail

HSV-1 and Alzheimer’s Disease: more than a hypothesis

By Roberto ePiacentini, Giovanna eDe Chiara, Domenica Donatella Li Puma, Cristian eRipoli, Maria Elena Marcocci, Enrico eGaraci, Anna Teresa Palamara, Anna Teresa Palamara and Claudio eGrassi

Abstract

Among the multiple factors concurring to Alzheimer’s Disease (AD) pathogenesis, greater attention should be devoted to the role played by infectious agents. Growing epidemiological and experimental evidence suggests that recurrent herpes simplex virus type-1 (HSV-1) infection is a risk factor for AD although the underlying molecular and functional mechanisms have not been fully elucidated yet. Here, we review literature suggesting the involvement of HSV-1 infection in AD also briefly mentioning possible pharmacological implications of these findings

Topics: Amyloid beta-Peptides, Alzheimer's disease, gamma-secretase, HSV-1, recurrent infection, Therapeutics. Pharmacology, RM1-950
Publisher: Frontiers Media S.A.
Year: 2014
DOI identifier: 10.3389/fphar.2014.00097/full
OAI identifier: oai:doaj.org/article:9670f99b8ac94c0590d76e21ac761dfc
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1663-9812 (external link)
  • http://journal.frontiersin.org... (external link)
  • https://doaj.org/article/9670f... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles